CD44 and breast carcinoma: Peng et al. [44] have shown that, in culture of human breast carcinoma cells, antibody-mediated CD44 cross-linking resulted in the colocalization of CD44 and MMP-9, which may augment the level of MMP-9 in the membrane, possibly implicated in the increased capacity of tumor invasion and metastasis.